Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter

Published 2 weeks ago Negative
Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter
Auto

Related Stocks

NOVN.SW Novartis AG
Novartis stock fell early Tuesday after a mixed third-quarter report that included a sales decline for heart-failure drug Entresto.

Continue Reading

View Comments

More News

Deepspatial Inc. Appoints New Auditors to Complete Outstanding Filings and Advance Toward CTO Revocation

13 hours ago Positive

EUR/USD holds in range as US government reopening hopes lift mood

16 hours ago Negative

NZD/USD hovers around 0.5640, downside likely on RBNZ rate cut bets

16 hours ago Negative

Earnings Snapshot: Rocket Lab surpasses Q3 expectations, sees stronger Q4 ahead

17 hours ago Positive

Shiba Inu (SHIB) Recovery Ends? 26 EMA Resistance Activated

17 hours ago Negative